AMYLIN PHARMACEUTICALS INC Restructuring Charges
AMYLIN PHARMACEUTICALS INC reported Restructuring Charges of $5.25 million for the 3-month period ending 2012-06-30, per its 10-Q filed 2012-08-03.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2012-08-03
- AMYLIN PHARMACEUTICALS INC restructuring charges for the quarter ending 2012-06-30 was $5.25M, a 4069.84% increase year-over-year.
- AMYLIN PHARMACEUTICALS INC restructuring charges for the quarter ending 2012-03-31 was $3.00M, a 4.97% increase year-over-year.
- AMYLIN PHARMACEUTICALS INC restructuring charges for the quarter ending 2011-12-31 was $1.71M, a 76.71% decline year-over-year.
- AMYLIN PHARMACEUTICALS INC restructuring charges for the quarter ending 2011-09-30 was $2.50M, a 58.54% decline year-over-year.
- AMYLIN PHARMACEUTICALS INC restructuring charges for fiscal 2011 was $7.19M, a 57.15% decline from fiscal 2010.
- AMYLIN PHARMACEUTICALS INC restructuring charges for fiscal 2010 was $16.78M, a 1.18% decline from fiscal 2009.
- AMYLIN PHARMACEUTICALS INC restructuring charges for fiscal 2009 was $16.98M.
| Period end | Restructuring Charges 3 month | Restructuring Charges 3 month as first filed | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|---|
| 2012-06-30 | $5.25M 10-Q · filed 2012-08-03 | $5.41M 10-Q · filed 2012-08-03 | $9.96M derived: sum of 3 quarters · filed 2012-08-03 | $12.46M derived: sum of 4 quarters · filed 2012-08-03 | |
| 2012-03-31 | $3.00M 10-Q · filed 2012-08-03 | $151.00K 10-Q · filed 2012-05-07 | $4.71M derived: sum of 2 quarters · filed 2012-08-03 | $7.21M derived: sum of 3 quarters · filed 2012-08-03 | $7.33M derived: sum of 4 quarters · filed 2012-08-03 |
| 2011-12-31 | $1.71M 10-K · filed 2012-02-22 | $4.21M derived: sum of 2 quarters · filed 2012-02-22 | $4.33M derived: sum of 3 quarters · filed 2012-08-03 | $7.19M 10-K · filed 2012-02-22 | |
| 2011-09-30 | $2.50M 10-K · filed 2012-02-22 | $2.63M derived: sum of 2 quarters · filed 2012-08-03 | $5.48M 10-Q · filed 2011-10-28 | $12.81M derived: sum of 4 quarters · filed 2012-08-03 | |
| 2011-06-30 | $126.00K 10-Q · filed 2012-08-03 | $2.98M 10-Q · filed 2012-08-03 | $10.31M derived: sum of 3 quarters · filed 2012-08-03 | $16.34M derived: sum of 4 quarters · filed 2012-08-03 | |
| 2011-03-31 | $2.86M 10-Q · filed 2012-05-07 | $10.19M derived: sum of 2 quarters · filed 2012-05-07 | $16.21M derived: sum of 3 quarters · filed 2012-05-07 | $19.64M derived: sum of 4 quarters · filed 2012-05-07 | |
| 2010-12-31 | $7.33M 10-K · filed 2012-02-22 | $13.36M derived: sum of 2 quarters · filed 2012-02-22 | $16.78M derived: sum of 3 quarters · filed 2012-02-22 | $16.78M 10-K · filed 2012-02-22 | |
| 2010-09-30 | $6.03M 10-K · filed 2012-02-22 | $9.45M derived: sum of 2 quarters · filed 2012-02-22 | |||
| 2010-06-30 | $3.42M 10-K · filed 2012-02-22 | ||||
| 2009-12-31 | $16.98M 10-K · filed 2012-02-22 |